menu
    • menu

    Company profile for Foresee Pharmaceuticals

    NEW Drugs in Dev: 10
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Foresee Pharmaceuticals Co., Ltd. (FP) is a clinical-stage pharmaceutical company. Our mission is to serve patients. We strive to improve patients' quality of life and provide cure through innovative research. We are committed to apply the highest ethical standards to our products, services and communications. Foresee's core competency includes rapid development and commercialization of new drugs using its proprietary drug del...
    Foresee Pharmaceuticals Co., Ltd. (FP) is a clinical-stage pharmaceutical company. Our mission is to serve patients. We strive to improve patients' quality of life and provide cure through innovative research. We are committed to apply the highest ethical standards to our products, services and communications. Foresee's core competency includes rapid development and commercialization of new drugs using its proprietary drug delivery technology as well as develop first-in-class NCE in disease areas of high unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Foresee PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    550 S college Ave, Suite 107, Newark, DE 19713, USA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.foreseepharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/foresee-pharmaceuticals-inc./?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Foresee Pharma Welcomes Chmp's Positive Opinion On CAMCEVI 21mg
    Foresee Pharma Welcomes Chmp's Positive Opinion On CAMCEVI 21mg

    06 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-welcomes-positive-chmp-opinion-recommending-approval-of-camcevi-21mg-3-month-strength-in-the-european-union-for-advanced-prostate-cancer-302706567.html

    PR NEWSWIRE
    06 Mar 2026
    Share Share
    Foresee Pharma Gets 4th DSMB Nod for Casppian Phase 3 in CPP
    Foresee Pharma Gets 4th DSMB Nod for Casppian Phase 3 in CPP

    04 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-receives-the-fourth-positive-recommendation-from-the-dsmb-to-continue-the-casppian-ph3-study-for-central-precocious-puberty-cpp-302678781.html

    PR NEWSWIRE
    04 Feb 2026
    Share Share
    Foresee Offloads Clinical-Stage MMP-12 Inhibitors In $584M Deal
    Foresee Offloads Clinical-Stage MMP-12 Inhibitors In $584M Deal

    08 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-global-licensing-agreement-for-mmp-12-inhibitors-with-primevera-therapeutics-llc-302656266.html

    PR NEWSWIRE
    08 Jan 2026
    Share Share
    Foresee Pharma: Casppian Ph 3 Study Meets LH Suppression Endpoint
    Foresee Pharma: Casppian Ph 3 Study Meets LH Suppression Endpoint

    24 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-the-casppian-phase-3-study-meets-primary-efficacy-endpoint-demonstrating-robust-lh-suppression-with-6-month-dosing-interval-of-leuprolide-mesylate-302649248.html

    PR NEWSWIRE
    24 Dec 2025
    Share Share
    Foresee Pharmaceuticals Announces FDA Approval of Camcevi ETM
    Foresee Pharmaceuticals Announces FDA Approval of Camcevi ETM

    29 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/foresee-pharmaceuticals-announces-fda-approval-of-camcevi-etm/

    CONTRACTPHARMA
    29 Aug 2025
    Share Share
    Foresee: First Dosed in Ph 2 WINDWARD Study of Mirivadelgat
    Foresee: First Dosed in Ph 2 WINDWARD Study of Mirivadelgat

    15 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-first-patient-dosed-in-the-phase-2-windward-study-of-the-aldh2-activator-mirivadelgat-for-patients-with-pulmonary-hypertension-associated-interstitial-lung-disease-ph-ild-302456261.html

    PR NEWSWIRE
    15 May 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search